Clinical Trial Update: MAG-PAIN - MAGnesium for Postoperative Analgesia In the Newly Delivered [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial entry (MAG-PAIN) evaluating magnesium sulfate for postoperative analgesia in newly delivered patients, with status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: Region Halland | Conditions: Postoperative Pain, Quality of Recovery (QoR-15) | Phase 2 | Status: NOT_YET_RECRUITING